These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3281028

  • 1. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
    Douple EB, Totten MD, Spencer F.
    NCI Monogr; 1988; (6):129-32. PubMed ID: 3281028
    [Abstract] [Full Text] [Related]

  • 2. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.
    Fu KK, DeGregorio MW, Phillips JW.
    NCI Monogr; 1988; (6):123-7. PubMed ID: 3281027
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL.
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [Abstract] [Full Text] [Related]

  • 5. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
    Kido Y, Khokhar AR, Yoshida M, Thai GW, Siddik ZH.
    Drug Metab Dispos; 1994 Nov; 22(2):312-7. PubMed ID: 8013287
    [Abstract] [Full Text] [Related]

  • 7. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET, Kelley M, Rockwell S.
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [Abstract] [Full Text] [Related]

  • 8. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP.
    Clin Cancer Res; 2004 May 15; 10(10):3386-95. PubMed ID: 15161693
    [Abstract] [Full Text] [Related]

  • 9. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B, Caty A, Fournier C, Lefebvre JL, Adenis L.
    Bull Cancer; 1987 May 15; 74(4):433-6. PubMed ID: 3311237
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 May 15; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 11. Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Zuhowski EG, Pluim D, Joseph E, Hamburger DR, Working PK, Colbern G, Tonda ME, Potter DM, Eiseman JL.
    Cancer Chemother Pharmacol; 2004 Apr 15; 53(4):329-36. PubMed ID: 14673619
    [Abstract] [Full Text] [Related]

  • 12. An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.
    Ewen C, Perera A, Hendry JH, McAuliffe CA, Sharma H, Fox BW.
    Cancer Chemother Pharmacol; 1988 Apr 15; 22(3):241-5. PubMed ID: 3044632
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
    van Hennik MB, van der Vijgh WJ, Klein I, Elferink F, Vermorken JB, Winograd B, Pinedo HM.
    Cancer Res; 1987 Dec 01; 47(23):6297-301. PubMed ID: 3315183
    [Abstract] [Full Text] [Related]

  • 14. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ.
    J Pharmacol Exp Ther; 2001 Jun 01; 297(3):1106-12. PubMed ID: 11356935
    [Abstract] [Full Text] [Related]

  • 15. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 01; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 16. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
    Nagase M, Nomura T, Nakajima T.
    Cancer Treat Rep; 1987 Sep 01; 71(9):825-9. PubMed ID: 3621215
    [Abstract] [Full Text] [Related]

  • 17. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK, Kwon YE.
    Cancer Chemother Pharmacol; 2007 Jul 01; 60(2):237-43. PubMed ID: 17089165
    [Abstract] [Full Text] [Related]

  • 18. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS.
    Cancer Res; 1994 Oct 15; 54(20):5380-6. PubMed ID: 7923169
    [Abstract] [Full Text] [Related]

  • 19. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR, Gerberich JL, Nowotnik DP, Howell SB.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.